Literature DB >> 32449012

Endothelial nitric oxide synthase (NOS3) rs2070744 polymorphism and risk for multiple sclerosis.

José A G Agúndez1, Elena García-Martín1, Christopher Rodríguez1, Julián Benito-León2,3, Jorge Millán-Pascual4, María Díaz-Sánchez3, Patricia Calleja3, Laura Turpín-Fenoll4, Hortensia Alonso-Navarro5, Esteban García-Albea6, José Francisco Plaza-Nieto5, Félix Javier Jiménez-Jiménez7,8.   

Abstract

The possible role of oxidative stress and nitric oxide (NO) in the pathogenesis of multiple sclerosis (MS) has been suggested by several neuropathological, biochemical, and experimental data. Because the single-nucleotide polymorphism (SNP) rs2070744 in the endothelial nitric oxide synthase (eNOS or NOS3) gene (chromosome 7q36.1) showed association with the risk for MS in Iranians, we attempted to replicate the possible association between this SNP and the risk for MS in the Caucasian Spanish population. The frequencies of NOS3rs2070744 genotypes and allelic variants in 300 patients diagnosed with MS and 380 healthy controls were assessed with a TaqMan-based qPCR assay. The possible influence of the genotype frequency on age at onset of MS, the severity of MS, clinical evolutive subtypes of MS, and HLA-DRB1*1501 genotype were also analyzed. The frequencies of rs2070744 genotypes and allelic variants were not associated with the risk of developing MS and were not influenced by gender, age at onset and severity of MS, the clinical subtype of MS or the HLA-DRB1*1501 genotype. This study found a lack of association between NOS3 rs2070744 SNP and the risk for MS in Caucasian Spanish people.

Entities:  

Keywords:  Genetic polymorphisms; Genetics; Multiple sclerosis; Nitric oxide; Nitric oxide synthase genes; Risk factors

Mesh:

Substances:

Year:  2020        PMID: 32449012     DOI: 10.1007/s00702-020-02211-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  1 in total

1.  Common Endothelial Nitric Oxide Synthase Single Nucleotide Polymorphisms are not Related With the Risk for Restless Legs Syndrome.

Authors:  Félix Javier Jiménez-Jiménez; Blanca G Agúndez; Javier Gómez-Tabales; Hortensia Alonso-Navarro; Laura Turpín-Fenoll; Jorge Millán-Pascual; Mónica Díez-Fairén; Ignacio Álvarez; Pau Pastor; Marisol Calleja; Rafael García-Ruiz; Santiago Navarro-Muñoz; Marta Recio-Bermejo; José Francisco Plaza-Nieto; Esteban García-Albea; Elena García-Martín; José A G Agúndez
Journal:  Front Pharmacol       Date:  2021-02-25       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.